Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan

Reuters07-21

<a href="https://laohu8.com/S/THRD">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan

Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2553447619?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-21 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553447619","market":"us","top_or_hot":-1,"title":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/THRD\">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThird Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-21 19:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/THRD\">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"THRD","symbol_name":"Third Harmonic Bio, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL8CRwXW:1","article_id":"2553447619","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553447619","pubTimestamp":1753095948,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12 of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15 of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"THRD":"Third Harmonic Bio, Inc.","BK4007":"制药"},"translate_title":"Third Harmonic Bio Inc.宣布自愿从纳斯达克退市并计划公司解散","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THRD":0.9},"content_text":"Third Harmonic Bio Inc. Announces Voluntary Delisting from Nasdaq and Corporate Dissolution Plan\n    \n\n        Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161486), on July 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2553447619","isCrawlerRequest":true}